Demand for chip-design software is booming, making Synopsys the chip-design name to own after Cadence's results. Cadence reported a record $8.2 billion backlog and raised its 2026 revenue-growth outlook to 21%; Synopsys is still about 12% below its May high, and all four models signal Long on Synopsys versus Flat on Cadence. x.com 

Cadence's IBD composite and EPS ratings of 90 support its standing as arguably the best in the 'making chips better' group after ASML. The screen estimates 2026 EPS growth of 18% and sales growth of 21%. Its chart is near a breakout after a long pullback. x.com 

Synopsys looks expensive at $415.99, trading at 52 times cash earnings and 42 times next year's, against the roughly 30 times software companies usually get. That puts fair value at about $250.75 to $319.14, so buyers are paying about 30% over fair. The read is valuation levels only, based on reported earnings and revenue estimates, without fundamental work. x.com 

Synopsys looks a bit too cheap at around 20x cash EPS. x.com 

Cadence Design Systems looks cheap against its earnings at 34x, while software companies usually get 40x. Fair value runs $335.71 to $427.26, or 40x next year's $9.54 forecast EPS give or take 12%, and it turns expensive above $348.22. The valuation leans on that forecast, with forward earnings 65% above trailing. This is a levels-only read from reported earnings and revenue estimates, not fundamental work. x.com 

Arm's valuation carries an absurd premium for the architecture layer. It trades at 91.9x EV/sales, far above its historical range, as Wall Street prices it as the mandatory royalty tollbooth for every custom AI chip. EDA leaders Cadence, at 30.1x, and Synopsys, at 21.2x, trade near the low end of their historical bands, priced like mature utilities, as the market stacks almost all the scarcity premium into Arm. x.com 

Cadence Design Systems is the tollbooth of chip design: nobody builds an AI processor without first paying for EDA software, a duopoly market. That shows in 88.9% gross margins and eight straight years of 16–21% EPS growth without a down year. It ranks first and is the highest-conviction name on the software map, with a 96.8 story score, 90.5 chart score and 93.6 composite; with both above 90, the argument is over. The stock sits about 2% from a fresh pivot. x.com  x.com 

Synopsys's OpenAI deal and investor day have blown up the bear case that frontier AI will disrupt chip-design software. When OpenAI has dominant leverage over a partner, as with Cerebras, it extracts big equity concessions; it did not with Synopsys. KeyBanc called the investor day perfectly executed, citing much better than expected initial FY27 guidance, higher long-term EDA and IP targets, margin expansion and new AWS and OpenAI partnerships, and raised its target while reiterating Overweight. … Show more

Synopsys is the clear stand-alone way to play an Intel turnaround. The picture is less certain once Tesla's involvement with Intel is factored in, since Tesla uses Cadence. x.com 

Synopsys merits Overweight and a $650 December 2026 target because EDA's near-permanent switching costs give a durable recurring floor, while emulation and AI-enhanced tools lift growth and margins. Synopsys, Cadence and Siemens EDA control most of the market, and switching toolchains costs engineering years. AI chip design drives emulation hours, and ML tools command a pricing premium. The target is about 40x $16.20 of earnings power exiting 2H CY26; China export controls are the key risk. … Show more